Received Mar 19, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 1 | 3004081 | PO / MO |
The patient took only one dose of Vivotif that expired in February; The patient took only one dose of Vivotif that expired in February; Case reference number US-BN-2025-001305 is a spontaneous case initially received from a pharmacist via Communication (reference number: USBAV25-1799) on 23-Jul-2025 and concerns a female patient with an unspecified age (also reported as late 50s). The patient's medical history and concomitant medication details were not provided. On an unspecified date, the patient took a dose of Vivotif (batch number: 3004081) orally, at an unknown dose, for travel. The patient took the dose of Vivotif that expired on 28-Feb-2025 (explicitly coded as expired vaccine used' and incomplete course of vaccination'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif. No further information was provided.; Reporter's Comments: A female patient of unspecified age (also reported as late 50s) took a dose of Vivotif for travel. The patient took only one dose of Vivotif that expired, which is considered as expired vaccine used and incomplete course of vaccination. It was unknown if the patient experienced any adverse event due to Vivotif. Expired product administered and incomplete course of vaccination are considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Expired product administered and incomplete course of vaccination are not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A female patient of unspecified age (also reported as late 50s) took a dose of Vivotif for travel. The patient took only one dose of Vivotif that expired, which is considered as expired vaccine used and incomplete course of vaccination. It was unknown if the patient experienced any adverse event due to Vivotif. Expired product administered and incomplete course of vaccination are considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Expired product administered and incomplete course of vaccination are not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: NONE